Introduction
Nowadays, the method of chemotherapy + radiation is widely used because it is more effective for cancer cells than normal cells.
However, patient’s quality of life is directly related to the targeting ability of treatment, so that method has some side effects.
So finding less toxic agents and choosing a precise delivery system is a task currently important.
Regulation of nan
In 2006 to 2007, Hayakawa
Micromolar 수준의 potency로 PI3K 억제효과를 가지는 생리활성물질(Hit compound) 발견
->한자리수의 nanomolar lead(선도물질) 개발
Broad spectrum PI3K inhibitor 로서 쓰임.
PI 103은 세포투과적.
ATP 와 경쟁하는 경쟁적 kinase inhibitor 이다. 일반적으로 100nM에 효과나타남
PI103은 Class Ia PI 30kinase isoform,